Theodoros Roumeliotis

25PUBLICATIONS
164CO-AUTHORS
Molecular targetsMolecular, biological, and multi-scale communicationsBiomedical instrumentationCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Feb 18, 2026
LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.

Renée L Flaherty, Flavia Hughes, George Sflomos

|Feb 02, 2026
UltraPlex-TMT: Expanding Isobaric Hyperplexing via Orthogonal Protease Cleavage.

Theodoros I Roumeliotis, Fernando J Sialana, Jenny Ho

|Jan 12, 2026
Unhooking the Hook: Optimization of the Aurora A Targeting PROTAC JB170 to CCT400028, an In Vitro Degrader Chemical Probe.

Jack A O'Hanlon, Katrin Gutsche, Juliane Elisabeth Müller

|Oct 16, 2025
Structural basis of T-loop-independent recognition and activation of CDKs by the CDK-activating kinase.

Victoria I Cushing, Amy J S McGeoch, Sophie L Williams

|Aug 27, 2025
Proteomic Landscapes of 3D and 2D Models of High-Grade Serous Ovarian Carcinoma: Implications for Carboplatin Response.

Jimmy Maillard, Theodoros I Roumeliotis, Ekta Paranjape

Pageof 5